Cialis is the brand name Eli Lilly gave to tadalafil, a PDE5 inhibitor the FDA first approved on November 21, 2003, for erectile dysfunction (ED). Tadalafil's longer half-life than sildenafil (Viagra) lets it work for up to 36 hours after an on-demand 10mg or 20mg dose, earning it the nickname 'the weekend pill.' In October 2011, the FDA also approved a low-dose 2.5mg or 5mg once-daily version of the identical tablet to treat benign prostatic hyperplasia (BPH), an enlarged prostate condition common in older men, either alone or combined with ED. Adcirca, a separate brand also made of tadalafil, was approved May 22, 2009, for pulmonary arterial hypertension (PAH) at a higher 40mg daily dose. Teva launched the first FDA-approved generic tadalafil on May 22, 2018, ending Eli Lilly's exclusive brand pricing.
Pricing in 2026 splits sharply along the brand-versus-generic line, much like other drugs that lost exclusivity years ago. Brand Cialis costs $15 to $83 per tablet at cash-pay pharmacies depending on strength, while generic tadalafil costs roughly $0.40 to $15 per tablet at the same counters once a manufacturer coupon or pharmacy discount program is applied. Commercial insurance rarely moves the price much for the ED indication, since most plans place brand Cialis on a high formulary tier or exclude it outright, pushing patients toward the cheap generic. Medicare adds a second layer that most patients do not expect: the diagnosis code on the prescription, not the tablet itself, decides whether the claim can even be processed as a Part D drug at all.
Telehealth platforms such as Hims, Ro, and PlushCare have also reshaped how patients buy tadalafil in 2026, often selling generic chewables or dissolvable formulations by monthly subscription for $20 to $30 without an in-person urology visit. Patients whose prescriber documents BPH rather than ED should ask their pharmacist to confirm the claim is being submitted under the correct diagnosis code, since that single detail determines whether Medicare Part D pays anything at all. Anyone weighing whether overall drug spending affects broader eligibility should also review the Medicaid income limits and federal poverty level guidelines, since prescription costs alone rarely drive eligibility but combined household medical spending can.
What Cialis Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same cialis can cost many times more at a hospital than at your local pharmacy:
2026 Cialis Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter, brand Cialis (cash) | $15 - $83/tablet | 2026 cash price, varies by 2.5mg, 5mg, 10mg, or 20mg strength and pharmacy |
| Pharmacy counter, generic tadalafil (cash) | $0.40 - $15/tablet | Lower end with a free GoodRx or SingleCare coupon; average retail without a coupon runs about $6.63/tablet in 2026 |
| Medicare Part D (2026) | Full cash price for ED; standard copay for BPH, capped at $2,100/year | ED use statutorily excluded under Social Security Act §1927(d)(2)(K); BPH use is a covered Part D drug |
| Commercial insurance | $10 - $40/month copay for generic BPH use after prior authorization; brand and ED use often excluded | Formulary tier and quantity limits (commonly 8-10 on-demand tablets or 30 daily tablets/month) vary by plan |
| Medicaid | $1 - $4/prescription in states that cover it, with prior authorization | Many states exclude ED-indicated tadalafil entirely under the optional 1927(d)(2)(K) Medicaid exclusion; BPH use coverage varies by state |
2026 retail prices reflect GoodRx, SingleCare, and pharmacy survey data. Because Medicare Part D cannot cover ED-indicated tadalafil by statute, no Part D copay tier applies for that use, but the identical tablet becomes a normal formulary-tier drug once the diagnosis code changes to BPH.
Source: GoodRx 2026 pricing survey, CMS Part D excluded drug guidance, state Medicaid preferred drug lists
Why Hospitals Charge So Much
Cialis and generic tadalafil rarely appear on inpatient hospital bills because both are self-administered oral tablets meant for outpatient use, either on-demand before sexual activity or once daily for BPH symptom control. Occasionally a hospital pharmacy dispenses a single dose during a urology consult or post-prostate-surgery recovery, and that single tablet can be billed at $150 to $400 once facility fees, pharmacy handling charges, and nursing administration markups are added. Patients who spot a tadalafil line item at those rates on an itemized 2026 bill should request the National Drug Code (NDC) and compare it against the wholesale cost of $0.40 to $15 per generic tablet.
Adcirca, the brand of tadalafil approved for pulmonary arterial hypertension at a higher 40mg once-daily dose, is billed and coded entirely separately from Cialis because it treats a different, non-excluded FDA-approved condition. That distinction matters most for Medicare beneficiaries reviewing an itemized bill, since a tadalafil charge tied to a PAH diagnosis follows normal Part D formulary rules and the 2026 out-of-pocket cap, while a charge tied to an ED diagnosis does not receive any Part D benefit at all regardless of the dollar amount.
Patient Assistance Programs
Eli Lilly, the manufacturer of Cialis, runs the Lilly Cares Foundation, a program that notably still lists Cialis among its Group 1 covered medications in 2026 even though inexpensive generic tadalafil has been available since 2018. That makes Cialis somewhat unusual compared to other legacy brand-name drugs whose manufacturers stop offering assistance once a cheap generic exists.
Patient assistance programs for Cialis| Manufacturer program | Cost / Benefit | How to apply |
|---|
| Lilly Cares Foundation Patient Assistance Program | $0 Cialis for uninsured or underinsured patients at or below 300% of the Federal Poverty Level, not enrolled in Medicaid, full Extra Help, or VA benefits | lillycares.com |
| NeedyMeds Drug Discount Card | Free discount card, no income limit; cuts generic tadalafil to roughly $0.40 to $2/tablet and brand Cialis substantially at participating pharmacies | needymeds.org |
| GoodRx / SingleCare coupon | Generic tadalafil for about $11.97 for a 30-count 5mg fill at participating pharmacies with a free coupon | goodrx.com |
| Mark Cuban Cost Plus Drugs | Cash-only online pharmacy selling generic tadalafil across multiple strengths at a transparent 15% markup over supplier cost, shipped directly with no insurance needed | costplusdrugs.com |
Federal anti-kickback law bars Medicare, Medicaid, TRICARE, and VA beneficiaries from using drug-company manufacturer coupons; that rule matters less for Cialis because Eli Lilly does not currently run an active commercial copay card for it. Medicare beneficiaries whose tadalafil is prescribed for ED cannot use any coupon to unlock Part D payment, since the exclusion is statutory, not plan-based; those prescribed tadalafil for BPH simply use their normal Part D benefit.
Source: Lilly Cares Foundation, NeedyMeds.org, GoodRx, Mark Cuban Cost Plus Drugs
Medicare Part D
Federal law statutorily excludes erectile dysfunction drugs from Medicare Part D coverage. Section 1927(d)(2)(K) of the Social Security Act lists agents used to treat sexual or erectile dysfunction among the drug classes that cannot be treated as a covered Part D drug, and CMS applies that exclusion uniformly across every Medicare Part D and Medicare Advantage prescription drug plan. That means the 2026 Part D annual out-of-pocket cap of $2,100 never applies to Cialis or generic tadalafil prescribed for ED, because spending on an excluded drug never counts toward Part D benefit calculations in the first place.
Tadalafil 2.5mg and 5mg daily tablets escape the exclusion entirely when the prescriber documents benign prostatic hyperplasia rather than erectile dysfunction. Most 2026 Medicare Part D and Medicare Advantage Prescription Drug (MAPD) plans will approve tadalafil for BPH as a normal covered drug subject to the plan's regular formulary tier, prior authorization criteria, and the 2026 out-of-pocket cap, provided the diagnosis code and prior authorization form clearly state BPH and not ED. Prescribers documenting the identical tablet strength for both conditions at once should expect closer scrutiny, since plans specifically watch for ED claims disguised as BPH claims.
The Inflation Reduction Act's Medicare Drug Price Negotiation Program, which set a Maximum Fair Price for 10 Part D drugs effective January 1, 2026, never considered tadalafil for any indication because CMS selects negotiated drugs from among the highest-spend covered Part D drugs, and tadalafil's total Part D spend (limited to the BPH indication) never approached the negotiation threshold. Beneficiaries frustrated that Cialis was not negotiated down like Eliquis or Jardiance should understand that spend volume and statutory eligibility, not oversight, kept it off the negotiation list.
Common Cialis Billing Errors
If a pharmacy or clinic bills you more than $15 per generic tadalafil tablet, or Medicare denies a BPH prescription outright, check for these issues before paying:
- Pharmacist filled the brand-name prescription instead of the generic because the prescriber checked 'dispense as written' out of habit. Ask your prescriber to specifically authorize generic substitution unless there is a documented medical reason not to.
- Claim coded for erectile dysfunction when the prescription is actually for benign prostatic hyperplasia, causing an automatic Part D denial. Confirm the ICD-10 diagnosis code on the claim matches the FDA-approved BPH indication your prescriber intended.
- Cash customer charged the pharmacy's undiscounted list price at the register instead of the lower price available with a free GoodRx or SingleCare coupon. Pharmacies are not required to volunteer the discount; ask the pharmacist to run the coupon.
- Daily 5mg BPH fill billed as if it were an on-demand 20mg ED fill, doubling or tripling the tablet count and the copay. Confirm the pharmacy dispensed the strength and quantity your prescriber actually intended.
- Hospital inpatient bill listing a single tadalafil tablet at $150 or more when the wholesale generic cost is $0.40 to $15. Request the itemized bill and NDC number and dispute facility markups above the wholesale acquisition cost.
Frequently Asked Questions
Is there a generic version of Cialis?
Yes. Generic tadalafil has been sold in the US since May 22, 2018, when Teva launched the first FDA-approved generic under a patent settlement with Eli Lilly. In 2026, generic tadalafil costs about $0.40 to $15 per tablet at major pharmacies with a discount coupon, compared to $15 to $83 per tablet for brand Cialis. The generic is chemically identical to the brand and works the same way for both erectile dysfunction and benign prostatic hyperplasia.
How do I apply for the Lilly Cares patient assistance program for Cialis?
Call 1-800-545-6962 or visit lillycares.com to request an application. You will need proof of household income at or below 300% of the Federal Poverty Level in 2026, proof of US residency, confirmation you are not enrolled in Medicaid or VA prescription benefits, and your prescriber's signature. If approved, Lilly Cares ships a 3-month supply of Cialis to your home or prescriber's office at no cost, and you renew annually.
Can I use a Cialis manufacturer coupon with Medicare?
Eli Lilly does not currently run an active commercial copay card for Cialis, and federal anti-kickback law would bar Medicare and Medicaid beneficiaries from using one even if it existed. The larger issue is that Medicare Part D is statutorily barred from covering erectile dysfunction drugs at all, so a manufacturer coupon would not interact with a Part D copay for that indication in the first place. Tadalafil prescribed for BPH is covered normally and needs no coupon.
What if my insurance denies coverage for Cialis?
If Medicare denied the claim for erectile dysfunction, no appeal will succeed because federal law excludes ED drugs from Part D by statute. For BPH-indicated tadalafil denials or commercial insurance denials, request the written denial notice and file a formal appeal through your plan within 60 to 180 days, or ask your prescriber for a peer-to-peer review. Given that generic tadalafil costs $0.40 to $15 per tablet in 2026, many patients find it faster to switch to the generic than to pursue a lengthy appeal for brand Cialis.
Does the Inflation Reduction Act's Maximum Fair Price apply to Cialis?
No. The Inflation Reduction Act's Medicare Drug Price Negotiation Program set a Maximum Fair Price for 10 Part D drugs effective January 1, 2026, including Eliquis and Jardiance, but CMS selects negotiated drugs based on the highest total Part D spending. Tadalafil's Part D spend, limited to the BPH indication since ED use is excluded, never approached the negotiation threshold, so Cialis has no Maximum Fair Price in 2026.
What does Cialis cost without insurance in 2026?
Brand Cialis costs $15 to $83 per tablet in cash at most pharmacies in 2026, depending on the strength prescribed. Generic tadalafil, chemically identical to Cialis, costs about $13.40 per tablet at Walmart and roughly $10.25 to $26.50 for a 30-count fill at other major chains depending on discount programs used. Because insurance rarely helps with the brand for the ED indication, comparing cash prices for the generic is usually the fastest way to save money.
Do I qualify for the Lilly Cares patient assistance program?
Lilly Cares generally requires household income at or below 300% of the Federal Poverty Level in 2026 (about $47,880 for a single person), no enrollment in Medicaid, full Extra Help, or VA prescription benefits, and a valid Cialis prescription. Unlike some manufacturer programs that exclude legacy ED drugs once cheap generics exist, Lilly Cares still lists Cialis on its Group 1 covered-medication list, making it a realistic option for eligible uninsured patients.
Does Medicare cover Cialis for benign prostatic hyperplasia even though it doesn't cover it for erectile dysfunction?
Yes. The same 2.5mg or 5mg daily tadalafil tablet is a normal covered Medicare Part D drug when prescribed and coded for benign prostatic hyperplasia (BPH), subject to the plan's formulary tier, prior authorization rules, and the 2026 out-of-pocket cap of $2,100. Federal law excludes only the erectile dysfunction indication under Section 1927(d)(2)(K) of the Social Security Act, so the diagnosis code your prescriber submits, not the tablet itself, determines whether Medicare pays.
